Dr. Barry Dworkin

Small in vitro study suggests two new COVID subvariants may dodge natural immunity response. However whether this translates into worsening clinical outcomes remains unanswered.

Medical Mythbusting Commentary for May 4, 2022

Source:
Two new subvariants of COVID appear to dodge natural immunity

Reference:

Omicron sub-lineages BA.4/BA.5 escape BA.1 infection elicited neutralizing immunity

Related posts:

  1. Still too early in the pandemic to determine how long immunity lasts after initial infection.
  2. Vulnerable populations to be the focus in a new Canadian COVID-19 antibody study.
  3. Study reports that people who had mild to moderate #COVID-19 have protective stable antibody levels five months after their infection. This finding and further studies to follow can help with public policy and vaccine development programs.
  4. Scientists discover antibodies capable of stopping several coronaviruses, potentially preventing future outbreaks